Form 4 for ELAN Elanco Animal Health Inc
Accepted 2021-12-02 00:00:00 ET · period of report 2021-11-30 · accession 0001179110-21-010543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-12-02 | 2021-11-30 | ELAN | HOOVER R DAVID | Dir | P - Purchase | $29.38 | +10.0K | 105.0K | +11% | +$293.8K |
| D | 2021-12-02 | 2021-11-30 | ELAN | HOOVER R DAVID | Dir | A - Grant | $0.00 | +7,307 | 39.3K | +23% | $0 |
| D | 2021-12-02 | 2021-11-30 | ELAN | HOOVER R DAVID | Dir | A - Grant | $28.74 | +742.29 | 18.9K | +4% | +$21.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-30 | P | A | 10,000 | $29.38 | 105,000 | I Revocable Trust | — | — | (F1) Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 30, 2021 with purchase prices ranging from $29.3587 to $29.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2021-11-30 | A | A | 7,307 | $0.00 | 39,267 | D | — | — | (F2) Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| 3 | Derivative | Deferred Stock Units | 2021-11-30 | A | A | 742.29 | $28.74 | 18,858.55 | D | — · — to — | 742.29 Common Stock | (F3) Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. (F4) The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. (F5) The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. |